Description
The pharma wholesale and distribution market is estimated to grow at a CAGR of 5.6% in the first half of the forecast period. The market is estimated to reach a revenue of $1.3bn in 2023. In 2017, the branded drugs submarket held 79% of the pharma wholesale and distribution market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 277-page report you will receive 93 tables and 107 figures, all unavailable elsewhere.
The 277-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Pharma Wholesale and Distribution Market from 2018-2028
• Forecast of the Global Pharma Wholesale and Distribution market by Category:
• Generic Drugs
• Branded Drugs
• Others
• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Japan
• China
• Brazil
• India
• Russia
• RoW
Each National Market is further segmented into generic drugs, branded drugs and others
• Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:
• Alfresa Holdings
• AmerisourceBergen
• Cardinal Health
• McKesson
• Medipal
• PHOENIX Group
• Shanghai Pharma
• SINOPHARM
• Suzuken
• Walgreens Boots Alliance
• This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.
Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.
Buy our report today Pharma Wholesale and Distribution Market Forecasts 2018-2028: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
